Antidotes to haemorrhage: recombinant factor VIIa-Reference-Cited by-同舟云学术

Antidotes to haemorrhage: recombinant factor VIIa

Published:2004-03 Issue:1 Volume:17 Page:183-197
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Kessler Craig M

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference60 articles.

1. Use of prothrombin complex concentrates in the management of bleeding in hemophiliacs with inhibitors-benefits and limitations;Lusher;Seminars in Hematology,1994

2. Tracing blood units to their recipients: results of a two-centre study;Ballard;Transfusion,2003

3. Transfusion risks of yesterday and of today;Allain;Transfusion clinique et biologique: Journalde la Societe francaise de transfusionsanguine,2003

4. Transmission of BSE by blood transfusion in sheep;Houston;Lancet,2000

5. Plasma and lipids from stored platelets cause acute lung injury in an animal model;Silimann;Transfusion,2003

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data;Critical Care;2008

2. The use of recombinant activated factor VII in traumatic intracranial haemorrhage;Srpski arhiv za celokupno lekarstvo;2008

3. Probable right atrial thrombus immediately after recombinant activated factor VII administration;British Journal of Anaesthesia;2007-08

4. Klinische Bewertung potentieller Einsatzbereiche von rekombinantem Faktor VIIa bei internistischen und pädiatrischen Erkrankungen;Medizinische Klinik;2007-01

5. Effects of Recombinant Activated Factor VII in Traumatic Nonsurgical Intracranial Hemorrhage;Current Surgery;2006-09